BIONTECH SE - AMERICAN DEPOSITARY SHARES

Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine

21 Oct 2021 06:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union

04 Oct 2021 12:10:00 By Nasdaq GlobeNewswire

BioNTech to Present New Clinical and Preclinical Data Across Multiple Immuno-Oncology Programs at 36th SITC Annual Meeting

01 Oct 2021 08:12:36 By Nasdaq GlobeNewswire

BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients

01 Oct 2021 02:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries

22 Sep 2021 06:02:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years

20 Sep 2021 06:45:00 By Nasdaq GlobeNewswire

FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations

18 Sep 2021 03:40:00 By Nasdaq GlobeNewswire

Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply

27 Aug 2021 07:15:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America

26 Aug 2021 06:46:32 By Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older

25 Aug 2021 12:10:00 By Nasdaq GlobeNewswire

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older

23 Aug 2021 11:55:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine

16 Aug 2021 11:31:14 By Nasdaq GlobeNewswire

BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update

09 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland

04 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021

02 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent

26 Jul 2021 10:00:00 By Nasdaq GlobeNewswire

Fighting Infectious Diseases on the African Continent

23 Jul 2021 09:50:25 By Nasdaq GlobeNewswire

Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

23 Jul 2021 06:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

21 Jul 2021 07:15:00 By Nasdaq GlobeNewswire

BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD

19 Jul 2021 08:00:00 By Nasdaq GlobeNewswire